pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
Coronavirus Disease 2019 (COVID-19) vaccine 1
Covid-19 Vaccine (mivalsecovatein [INN])
Coronavirus Disease 2019 (COVID-19)
$NVAXNOVAVAX INC
0 catalysts
Preclinical
Coronavirus Disease 2019 (COVID-19) vaccines
Coronavirus Disease 2019 (COVID-19)
University of Florida
0 catalysts
Marketed
Coronavirus Disease 2019 (SARS-CoV-2) vaccine 2
Spikevax Omicron XBB.1.5
Coronavirus Disease 2019 (COVID-19)
$MRNAModerna, Inc.
0 catalysts
← prev
page 82 of 271
next →
131
Pain89
Neurology1
Marketed
Cortef
Cortef (hydrocortisone acetate)
Acute Rheumatic Heart Disease
$PFEPFIZER INC
0 catalysts
Marketed
Cortenema
Cortenema (hydrocortisone [INN])
Proctitis
$ANIPANI PHARMACEUTICALS INC
0 catalysts
Marketed
Cortifoam
Cortifoam (hydrocortisone acetate)
Proctitis
Mylan Specialty LP
0 catalysts
Marketed
Creon
Creon (pancrelipase)
Exocrine Pancreatic Insufficiency
$ABBVAbbVie Inc.
0 catalysts
Marketed
Crestor
Crestor (rosuvastatin calcium)
Atherosclerosis
AstraZeneca Pharmaceuticals LP
0 catalysts
Marketed
Crexont
Crexont ((carbidopa + levodopa))
Parkinson's Disease
$AMRXAmneal Pharmaceuticals, Inc.
0 catalysts
Preclinical
Culnexin Inhibitors
Triple-Negative Breast Cancer (TNBC)
Culnexin Therapeutics LLC
0 catalysts
Marketed
Cusimolol
Timolol Maleate (timolol maleate)
Ocular Hypertension
Eon Labs Inc
0 catalysts
Marketed
Cutaquig
Cutaquig (immune globulin (human))
Primary Immune Deficiency (PID)
$PFEPFIZER INC
0 catalysts
Marketed
Cutivate
Cutivate Fougera (fluticasone propionate)
Atopic Dermatitis (Atopic Eczema)
Fougera Pharmaceuticals Inc
0 catalysts
Marketed
Cuvitru
Cuvitru (immune globulin (human))
Primary Humoral Immune Deficiencies
Takeda Pharmaceuticals USA Inc
0 catalysts
Phase 2
CybroCell
Degenerative Disc Disease
$FBLGFibroBiologics, Inc.
0 catalysts
Marketed
Cyclobenzaprine Hydrochloride Teva
Cyclobenzaprine Hydrochloride (cyclobenzaprine hydrochloride)
Muscle Spasm
Pliva Inc (Inactive)
0 catalysts
Marketed
Cyfendus
Anthrax
$EBSEmergent BioSolutions Inc.
0 catalysts
Marketed
Cytarabine Pfizer
Cytarabine (cytarabine)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$PFEPFIZER INC
0 catalysts
Preclinical
Cyto-111
Botulism
CytoDel Inc
0 catalysts
Phase 2
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK)
Refractory Acute Myeloid Leukemia
Cincinnati Children's Hospital Medical Center
0 catalysts
Marketed
Cytoxan
Cytoxan (cyclophosphamide [INN])
Nephrotic Syndrome
Baxter Healthcare Corp
0 catalysts
Phase 2
D-0120
Gouty Arthritis (Gout)
InventisBio Co Ltd
0 catalysts
Phase 1
D-121
Visceral Leishmaniasis (Kala-Azar)
Oblita Therapeutics BVBA
0 catalysts
Marketed
D-Penamine
Depen (penicillamine)
Rheumatoid Arthritis
Mylan Specialty LP
0 catalysts
Preclinical
D-Psilocybin
Major Depressive Disorder
Lennham Pharmaceuticals Inc
0 catalysts
Phase 2
D2C7-IT
Glioblastoma Multiforme (GBM)
Istari Oncology Inc
0 catalysts
Phase 1
D3L-001
Gastric Cancer
D3 Bio Inc
0 catalysts
Phase 2
D3S-002
Non-Small Cell Lung Cancer
D3 Bio Inc
0 catalysts
Phase 1
D3S-003
Solid Tumor
D3 Bio Inc
0 catalysts
Phase 1
DA-1726
Obesity
$MTVAMetaVia Inc.
0 catalysts